Granahan Investment Management Crispr Therapeutics Agnamen Akt ownership

Crispr Therapeutics Agnamen Akt's ticker is CRSP and the CUSIP is H17182108. A total of 316 filers reported holding Crispr Therapeutics Agnamen Akt in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Granahan Investment Management ownership history of Crispr Therapeutics Agnamen Akt
ValueSharesWeighting
Q1 2022$5,781
+60.4%
92,106
+93.7%
0.14%
+94.6%
Q4 2021$3,603
-29.0%
47,541
+4.9%
0.07%
-22.9%
Q3 2021$5,074
-38.9%
45,330
-11.6%
0.10%
-38.1%
Q2 2021$8,304
+41.2%
51,292
+6.2%
0.16%
+24.0%
Q1 2021$5,882
-32.8%
48,275
-15.6%
0.12%
-36.5%
Q4 2020$8,757
+166.2%
57,197
+45.4%
0.20%
+75.9%
Q3 2020$3,290
+2.6%
39,334
-9.8%
0.11%
-3.4%
Q2 2020$3,206
+121.6%
43,625
+27.8%
0.12%
+48.7%
Q1 2020$1,447
-31.3%
34,127
-1.3%
0.08%
-19.6%
Q4 2019$2,106
+48.5%
34,5820.0%0.10%
+24.4%
Q3 2019$1,418
-5.7%
34,582
+8.3%
0.08%
+5.4%
Q2 2019$1,504
+28.9%
31,927
-2.2%
0.07%
+17.5%
Q1 2019$1,167
+16.7%
32,657
-6.7%
0.06%
-11.3%
Q4 2018$1,000
-52.4%
34,992
-26.1%
0.07%
-37.7%
Q3 2018$2,100
-62.3%
47,342
-50.1%
0.11%
-66.1%
Q2 2018$5,570
+40.5%
94,791
+9.3%
0.34%
+17.5%
Q1 2018$3,965
+19.6%
86,743
-38.5%
0.29%
+9.6%
Q4 2017$3,314
-29.7%
141,140
-46.5%
0.26%
-33.6%
Q3 2017$4,713
+69.2%
263,746
+51.7%
0.39%
+52.9%
Q2 2017$2,786173,9070.26%